ZA942872B - Transdermal therapeutic systems for administering active substances - Google Patents

Transdermal therapeutic systems for administering active substances

Info

Publication number: ZA942872B
Authority: ZA; South Africa
Prior art keywords: active substances; transdermal therapeutic; therapeutic systems; administering active; administering
Prior art date: 1993-05-06

Application number

ZA942872A

Other languages

English (en)

Inventor

Harald Dr List

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-06

Filing date

1994-04-26

Publication date

1995-07-06

1994-04-26 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

1995-07-06 Publication of ZA942872B publication Critical patent/ZA942872B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA942872A 1993-05-06 1994-04-26 Transdermal therapeutic systems for administering active substances ZA942872B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4314976A DE4314976C1 (de)	1993-05-06	1993-05-06	Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number	Publication Date
ZA942872B true ZA942872B (en)	1995-07-06

Family

ID=6487316

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA942872A ZA942872B (en)	1993-05-06	1994-04-26	Transdermal therapeutic systems for administering active substances

Country Status (20)

Country	Link
EP (1)	EP0697869B1 (xx)
JP (1)	JPH08509749A (xx)
KR (1)	KR960702306A (xx)
AT (1)	ATE183392T1 (xx)
AU (1)	AU686159B2 (xx)
CA (1)	CA2160776A1 (xx)
CZ (1)	CZ289395A3 (xx)
DE (2)	DE4314976C1 (xx)
DK (1)	DK0697869T3 (xx)
ES (1)	ES2138659T3 (xx)
FI (1)	FI955260A7 (xx)
GR (1)	GR3031639T3 (xx)
HU (1)	HUT74865A (xx)
IL (1)	IL109509A (xx)
NO (1)	NO954414L (xx)
NZ (1)	NZ265949A (xx)
PL (1)	PL179353B1 (xx)
SK (1)	SK138095A3 (xx)
WO (1)	WO1994026270A1 (xx)
ZA (1)	ZA942872B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4467396A (en)	1994-12-12	1996-07-10	Omeros Medical Systems, Inc.	Irrigation solution and method for inhibition of pain, inflammation and spasm
US8022095B2 (en)	1996-08-16	2011-09-20	Pozen, Inc.	Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
JP4575632B2 (ja) *	1999-12-14	2010-11-04	帝國製薬株式会社	片頭痛緩和用薬剤
EP1435945B1 (en) *	2001-06-05	2008-08-13	Aung-din, Ronald	Topical migraine therapy
US8329734B2 (en)	2009-07-27	2012-12-11	Afgin Pharma Llc	Topical therapy for migraine
US7332183B2 (en)	2002-12-26	2008-02-19	Pozen Inc.	Multilayer dosage forms containing NSAIDs and triptans
WO2004112723A2 (en)	2003-06-20	2004-12-29	Ronald Aung-Din	Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
WO2007094876A2 (en) *	2005-12-20	2007-08-23	Teikoku Pharma Usa, Inc.	Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
CA2935569A1 (en)	2006-04-13	2007-10-25	Teva Pharmaceuticals International Gmbh	Transdermal methods and systems for the delivery of anti-migraine compounds
WO2010005507A1 (en)	2008-06-30	2010-01-14	Afgin Pharma, Llc	Topical regional neuro-affective therapy
US11337962B2 (en)	2009-09-25	2022-05-24	Upsher-Smith Laboratories, Llc	Formulations comprising triptan compounds
EP2480197B1 (en)	2009-09-25	2015-11-11	Dr. Reddy's Laboratories Ltd.	Formulations comprising triptan compounds
JP6216151B2 (ja) *	2013-04-19	2017-10-18	コスメディ製薬株式会社	親水性薬物のエマルジョンパッチ
EP3265081A4 (en)	2015-03-02	2018-11-21	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en)	2015-03-02	2019-08-20	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en)	2016-08-16	2018-02-22	Afgin Pharma, Llc	Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3742951A (en) *	1971-08-09	1973-07-03	Alza Corp	Bandage for controlled release of vasodilators
US3996934A (en) *	1971-08-09	1976-12-14	Alza Corporation	Medical bandage
US5288498A (en) *	1985-05-01	1994-02-22	University Of Utah Research Foundation	Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) *	1984-08-01	1988-02-24	Glaxo Group Ltd	An indole derivative
WO1992000103A1 (en) *	1990-06-28	1992-01-09	Beecham Group Plc	Pharmaceutical preparations
GB9103770D0 (en) *	1991-02-22	1991-04-10	Glaxo Group Ltd	Chemical compounds
GB9104890D0 (en) *	1991-03-08	1991-04-24	Glaxo Group Ltd	Compositions

1993
- 1993-05-06 DE DE4314976A patent/DE4314976C1/de not_active Expired - Fee Related
1994
- 1994-04-25 HU HU9503167A patent/HUT74865A/hu unknown
- 1994-04-25 FI FI955260A patent/FI955260A7/fi unknown
- 1994-04-25 JP JP6524861A patent/JPH08509749A/ja not_active Ceased
- 1994-04-25 AU AU66480/94A patent/AU686159B2/en not_active Ceased
- 1994-04-25 CZ CZ952893A patent/CZ289395A3/cs unknown
- 1994-04-25 PL PL94311591A patent/PL179353B1/pl unknown
- 1994-04-25 NZ NZ265949A patent/NZ265949A/en unknown
- 1994-04-25 DK DK94915109T patent/DK0697869T3/da active
- 1994-04-25 ES ES94915109T patent/ES2138659T3/es not_active Expired - Lifetime
- 1994-04-25 EP EP94915109A patent/EP0697869B1/de not_active Expired - Lifetime
- 1994-04-25 AT AT94915109T patent/ATE183392T1/de active
- 1994-04-25 SK SK1380-95A patent/SK138095A3/sk unknown
- 1994-04-25 CA CA002160776A patent/CA2160776A1/en not_active Abandoned
- 1994-04-25 DE DE59408643T patent/DE59408643D1/de not_active Expired - Lifetime
- 1994-04-25 WO PCT/EP1994/001280 patent/WO1994026270A1/de not_active Ceased
- 1994-04-26 ZA ZA942872A patent/ZA942872B/xx unknown
- 1994-05-02 IL IL10950994A patent/IL109509A/xx not_active IP Right Cessation
1995
- 1995-11-03 NO NO954414A patent/NO954414L/no not_active Application Discontinuation
- 1995-11-06 KR KR1019950705045A patent/KR960702306A/ko not_active Abandoned
1999
- 1999-10-27 GR GR990402728T patent/GR3031639T3/el unknown

Also Published As

Publication number	Publication date
JPH08509749A (ja)	1996-10-15
HU9503167D0 (en)	1996-01-29
PL179353B1 (en)	2000-08-31
CA2160776A1 (en)	1994-11-24
AU6648094A (en)	1994-12-12
ES2138659T3 (es)	2000-01-16
KR960702306A (ko)	1996-04-27
DK0697869T3 (da)	2000-03-20
FI955260L (fi)	1995-11-17
NO954414D0 (no)	1995-11-03
GR3031639T3 (en)	2000-02-29
IL109509A (en)	1999-12-22
SK138095A3 (en)	1996-06-05
EP0697869A1 (de)	1996-02-28
NO954414L (no)	1995-11-03
IL109509A0 (en)	1994-08-26
FI955260A7 (fi)	1995-11-17
EP0697869B1 (de)	1999-08-18
ATE183392T1 (de)	1999-09-15
DE59408643D1 (de)	1999-09-23
NZ265949A (en)	1997-10-24
FI955260A0 (fi)	1995-11-02
HUT74865A (en)	1997-02-28
DE4314976C1 (de)	1994-10-06
AU686159B2 (en)	1998-02-05
PL311591A1 (en)	1996-02-19
CZ289395A3 (en)	1996-04-17
WO1994026270A1 (de)	1994-11-24

Publication	Publication Date	Title
ZA942872B (en)	1995-07-06	Transdermal therapeutic systems for administering active substances
FI930862A0 (fi)	1993-02-25	En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
ATE220896T1 (de)	2002-08-15	Hydrogelformulierung mit gesteuerter freisetzung
AU4449789A (en)	1990-05-31	Delivery system for pharmaceutical or therapeutic actives
ZA982911B (en)	1998-10-09	Drug delivery system for two or more active substances
AU6675198A (en)	1998-09-18	Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
PL331709A1 (en)	1999-08-02	Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles
WO1997037640A3 (en)	1997-11-13	Uniform drug delivery therapy
BR9608255A (pt)	1999-02-02	Sistema terapéutico transdérmico (stt) para a administração de testosterona
ZA968905B (en)	1997-05-28	Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
GEP20043157B (en)	2004-01-26	Medicament Against Migraine Recurrence
PL348202A1 (en)	2002-05-06	Pharmaceutically active composition and dispensing device
MX9709453A (es)	1998-02-28	Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
CA2331414A1 (en)	1999-11-11	Transdermal therapeutic system for the administration of candesartan
ZA963744B (en)	1996-11-21	Topical aciclovir preparation
IL96506A0 (en)	1991-08-16	Transdermal system for administering pharmaceutical compounds under ph control
SI0697869T1 (en)	1999-12-31	Transdermal therapeutic systems for the administration of serotonin agonists
ZA966083B (en)	1998-06-19	Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
MX9605190A (es)	1997-09-30	Forma de dosis efectiva para farmacos antiepilepticos.
MX9705324A (es)	1997-10-31	Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas.
NO931208L (no)	1993-04-27	Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike